|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
3/12/20 Y-mAbs Therapeutics, Inc. 10-K 12/31/19 81:7.8M Toppan Merrill Bridge/FA
12/31/19 WG Biotech ApS 4 10% Owner² 1:4K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/31/19 Gad Thomas 4 Dir.,Off.² 1:6K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
12/31/19 Wedell-Wedellsborg Johan 4 Director² 1:6K Y-mAbs Therapeutics, Inc. Toppan Merrill/FA
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 10-K | Annual Report — Form 10-K. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|